Incyte
INCY
#1060
Rank
S$29.38 B
Marketcap
S$147.07
Share price
5.78%
Change (1 day)
69.27%
Change (1 year)

Incyte (INCY) - Total assets

Total assets on the balance sheet as of March 2026 : S$9.48 Billion

According to Incyte's latest financial reports the company's total assets are S$9.48 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Incyte - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31S$8.93 B20.72%
2024-12-31S$7.40 B-17.38%
2023-12-31S$8.95 B14.39%
2022-12-31S$7.83 B17.41%
2021-12-31S$6.66 B41.58%
2020-12-31S$4.71 B1.97%
2019-12-31S$4.61 B27.81%
2018-12-31S$3.61 B17.37%
2017-12-31S$3.07 B29.86%
2016-12-31S$2.37 B66.42%
2015-12-31S$1.42 B35.41%
2014-12-31S$1.05 B31.94%
2013-12-31S$0.79 B97.4%
2012-12-31S$0.40 B-5.15%
2011-12-31S$0.42 B-32.45%
2010-12-31S$0.63 B-36.94%
2009-12-31S$1.00 B200.94%
2008-12-31S$0.33 B-16.23%
2007-12-31S$0.39 B-26.83%
2006-12-31S$0.54 B-12.95%
2005-12-31S$0.62 B-26.14%
2004-12-31S$0.84 B30.78%
2003-12-31S$0.64 B-32.69%
2002-12-31S$0.95 B-26.65%
2001-12-31S$1.30 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Novartis
NVS
S$153.25 B 1,515.07%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$268.44 B 2,728.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$150.72 B 1,488.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$119.60 B 1,160.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$1.98 B-79.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
S$0.73 B-92.23%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
S$0.14 B-98.47%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
S$0.13 B-98.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
S$0.65 B-93.13%๐Ÿ‡บ๐Ÿ‡ธ USA